Longevity Services & Practice Library
Every article, presentation, spotlight, and news item we've tagged to Longevity Services & Practice.
Showing 145–168 of 245
Metabolic Aging: From Clinical Management to Systems Optimization
Metabolic health is transitioning from a narrow clinical category to a multidisciplinary optimization target, driven by consumer-oriented virtual care, continuous monitoring technologies, and integrated behavioral support. This shift recognizes metabolic function as a primary determinant of biological aging and systemic health, not merely weight management.
Klotho Longevity Therapy: Clinical Implementation and Biomarker Response
GARM Clinic conducted the inaugural Klotho Longevity Residency, administering a proprietary Klotho therapy via lipid nanoparticle platform to 22 participants and measuring individualized biomarker responses. The event represents a clinical implementation model that combines direct researcher-patient engagement with supervised biological intervention and biomarker tracking.
Global Conference to Tackle Longevity Clinical Translation
The NUS Academy for Healthy Longevity is hosting a Geromedicine Conference in February 2026 to advance the clinical translation of geroscience research into practical interventions. The event will focus on implementing evidence-based strategies including targeted molecules, bioactive compounds, and repurposed pharmaceuticals within personalized care frameworks.
Human Longevity, Inc. to study centenarians with LEV Foundation
Human Longevity, Inc. and LEV Foundation are conducting multi-omic analyses of centenarians and supercentenarians to identify molecular biomarkers and pathways associated with exceptional longevity. This research bridges the gap between identifying what distinguishes the longest-lived individuals and developing interventions that could extend healthspan in broader populations.
Genomic profiling targets aging through personalized health optimization
Aman Clinics and Cenegenics have launched a precision health optimization center in Doha that integrates genomic profiling, biomarker evaluation, and metabolic assessment to create individualized aging protocols. This represents the expansion of a clinical model with nearly three decades of outcomes data into a new geographic market, bringing systematic approaches to proactive health optimization beyond reactive medicine.
Can medicine outrun aging? Gerontologist says odds are improving
Longevity escape velocity (LEV) describes the point at which medical interventions extend life faster than aging progresses, requiring a repair-based approach to cellular and molecular damage rather than slowing decline alone. De Grey argues that demonstrating rejuvenation success in animal models will shift scientific consensus and accelerate translation to human therapies.
The pursuit of understanding human longevity
Extreme longevity does not require genetic predisposition to exceptional health; rather, it emerges from multifactorial resilience combining protective genetics, metabolic efficiency, low systemic inflammation, and sustained lifestyle choices. This reframes centenarian health as an achievable outcome of integrated biological and environmental factors rather than an exceptional outlier.
Function Health pushes comprehensive diagnostics, hormone testing
Function Health positions comprehensive lab testing—160+ markers including metabolic and hormonal panels—as a foundation for preventive health monitoring, with emphasis on insulin, cortisol, thyroid, and leptin assessment to detect metabolic dysregulation earlier than standard screening. The model links biomarker tracking to lifestyle factors to inform individualized health optimization and support longitudinal monitoring.
Is longevity ethical? A conversation the industry can’t avoid
This discussion reframes longevity from a pursuit of extreme lifespan extension toward a more grounded question: who benefits from living well longer, and under what conditions? The conversation bridges clinical evidence with ethical policy, arguing that longevity science should be evaluated by the same standards of safety, equity, and access applied to other medical fields.
Allen Law’s moonshot vision for the Longevity Century
Allen Law proposes that extending healthspan—not merely lifespan—is the central health challenge of the 21st century. The infrastructure and systems to support longer, stronger lives exist in scientific literature but remain inaccessible at scale; closing the 9.6-year gap between lifespan and healthspan requires proactive, preventive health built into daily life rather than reactive medicine.
‘We are not at consensus but we are at convergence’
The longevity field is moving from theoretical frameworks toward measurement-based clinical practice, with epigenetic clocks and multi-omics tools providing quantifiable biological age metrics that enable longitudinal tracking and personalized intervention. Precision assessment is becoming foundational to translating longevity research into actionable clinical protocols.
Biohacking market projected to top US$216 billion by 2035
The global biohacking market is projected to grow from US$38.05 billion in 2025 to US$216.68 billion by 2035, driven by consumer demand for self-tracking, personalized health optimization, and continuous sensing technologies. This expansion reflects a shift from consumer fitness gadgets toward clinical-grade diagnostics and subscription-based health management integrated into daily life.
Elitra Health launches concierge primary care program
Elitra Health launched a concierge primary care program limiting physician panels to 35 patients and offering 24/7 access, same-day appointments, and integrated preventive care coordination. The model prioritizes continuity of care and early detection through advanced diagnostics and personalized wellness planning as an alternative to volume-based primary care.
The oldest old become longevity biotech’s new map
Human Longevity, Inc. and LEV Foundation are analyzing blood samples from centenarians and supercentenarians using multi-omic analysis to identify molecular and cellular patterns associated with exceptional longevity. This approach shifts the field from theoretical prediction toward evidence grounded in individuals who demonstrate sustained resilience across the human lifespan.
Plug-and-play peptides hit longevity and wellness market
LifespanningRx has launched a plug-and-play platform enabling wellness businesses to offer peptide therapy within 24 hours without inventory management, regulatory overhead, or upfront investment. This model addresses the growing demand for personalized longevity interventions by removing operational barriers and shifting competition from the therapies themselves to seamless delivery infrastructure.
Precision Biomarkers Replace Reactive Screening
Aman Clinics has launched Cenegenics' precision health program in Qatar, marking the first physician-led longevity model in the region. The program shifts from reactive treatment to proactive assessment of aging biomarkers and metabolic risk before symptoms develop, embedding preventive medicine into mainstream clinical care.
New longevity drug SRN-901 shows 33% lifespan boost
SRN-901, a five-component oral combination therapy, demonstrated a 33% increase in median lifespan and 70% reduction in frailty progression in mice, with preserved physical function and reduced tumor incidence. The multi-pathway approach contrasts with single-target interventions, suggesting that aging requires simultaneous modulation of interconnected biological processes rather than isolated molecular manipulation.
LifespanningRx expands regenerative offering with RegenTherapy
LifespanningRx and RegenTherapy have partnered to integrate CellGen Factors—a cell signaling technology platform—into a consumer-accessible longevity program. The collaboration combines commercial infrastructure with clinical regenerative medicine expertise to deliver structured protocols for cellular recovery and performance optimization.
AI systems integration reshapes longevity beyond single biomarkers
Immorta Bio proposes that longevity optimization depends not on identifying a single aging biomarker, but on integrating thousands of biological signals through artificial intelligence, digital models, and patient-controlled data. This systems-based approach addresses a critical gap in precision medicine: the inability of isolated measurements to capture the body's interconnected complexity.
Forever Young explores the longevity revolution
A new documentary translates geroscience research into accessible language for public audiences, emphasizing that lifestyle and environmental factors—not genetic destiny—are the primary drivers of aging outcomes. This shift from genetic determinism to behavioral agency represents a critical moment in moving longevity science from laboratory to practical application.
How to live a long and healthy life, according to the ancients
Ancient Greek and Roman physicians documented longevity patterns through detailed case studies, identifying consistent behavioral practices—meal frequency, diet composition, daily movement, and recovery protocols—that correlated with extended healthspan. These observations predate modern gerontology by nearly two millennia yet align substantively with contemporary longevity research.
Rejuvenation Roundup April 2026
This April 2026 roundup surveys emerging research across multiple aging pathways: metabolic dysfunction accelerates aging in sedentary populations, enzymatic depletion drives cellular senescence in fat tissue, meal timing influences biological aging rates, and targeted interventions—from NAD+ restoration to immune mobilization via sauna—show measurable effects on muscle, cognition, and immune function in animal models.
Genomic precision medicine delays major disease by 20-30 years
Dr. Wei-Wu He, CEO of Human Longevity Inc., outlines a data-driven precision medicine platform built on genomic sequencing, multi-system phenotypic measurement, and longitudinal patient data to delay major age-related diseases by 20-30 years. The company has shifted from broad research ambitions to focused algorithmic development, now advancing collaborations that position it to scale personalized health optimization across populations.
Healthspan Over Lifespan: Italy's Validated Longevity Framework
Italy's National Health Service is developing an evidence-based framework to incorporate healthspan—years lived with preserved function—as a measurable outcome alongside life expectancy. The proposal outlines a staged adoption pathway for aging biomarkers, digital monitoring, and preventive interventions, requiring clinical utility and cost-effectiveness validation before implementation in routine care.